Jiangxi Yintao Pharmaceutical Co., Ltd.

Based on preclinical studies, this study used "change in throat pain VAS score compared with baseline on the 3rd day" as the main efficacy indicator, and adopted a randomized, double-blind, placebo-controlled, multicenter clinical verification trial design to evaluate the efficacy and safety of Xingxiang Tuerfeng Capsule in the treatment of acute pharyngitis (lung and stomach heat syndrome), to supplement the results of previous clinical studies, and to provide a basis for adding the indication of "treatment of acute pharyngitis".

To preliminarily evaluate the efficacy and safety of Yanli Capsule in the treatment of functional erectile dysfunction (kidney yang deficiency syndrome).

① Using placebo as control, preliminarily evaluate the effectiveness of Yanli Capsule in the treatment of functional erectile dysfunction-kidney yang deficiency syndrome. ② Preliminarily evaluate the safety of Yanli Capsule in patients with functional erectile dysfunction-kidney yang deficiency syndrome.